This chemical is primarily utilized in the synthesis of pharmaceuticals, particularly in the development of chiral compounds. Its structure makes it a valuable intermediate for producing active pharmaceutical ingredients (APIs) that require specific stereochemistry. It is often employed in the creation of drugs targeting neurological disorders, as its pyrrolidinone ring is a common motif in molecules designed to interact with the central nervous system. Additionally, it serves as a building block in organic synthesis for constructing complex molecules with potential therapeutic applications. Its bromomethyl group allows for further functionalization, enabling the creation of diverse derivatives for drug discovery and development.